Jason Aryeh - 21 Apr 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Issuer symbol
ANEB
Transactions as of
21 Apr 2022
Net transactions value
$0
Form type
4
Filing time
03 Oct 2022, 19:53:40 UTC
Previous filing
07 Jun 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +30,425 $0.000000 30,425 21 Apr 2022 Common Stock 30,425 $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested.